Next-Generation Complement-Targeted Gene Therapies in Complement Mediated Diseases
Time: 11:40 am
day: Conference Day Two
Details:
- Reviewing Kriya’s gene therapies that precisely target dysregulation and hyperactivity of the complement system
- Detailing the advantages of using gene therapy to target Geographic Atrophy and other ocular diseases
- Looking forward to the next steps for Kriya
